<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90647">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01924975</url>
  </required_header>
  <id_info>
    <org_study_id>V-line study</org_study_id>
    <nct_id>NCT01924975</nct_id>
  </id_info>
  <brief_title>Saphenous Vein Cannulation in Infants and Small Children</brief_title>
  <official_title>Ultrasound-image Guided Versus Traditional Landmark Technique for Saphenous Vein Cannulation in Infants and Small Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the two different saphenous vein cannulation
      techniques; real-time ultrasound image-guided technique (Ultrasound group) vs. traditional
      landmark technique (Landmark group).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Object is to Compare the First Attempt Success Rate Between Ultrasound Group and Landmark Group for Saphenous Vein Cannulation.</measure>
    <time_frame>10 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>A Comparison Will be Made Between Groups for Overall Success Rate Within 3 Attempt of Needle Insertions or a 10 Minute Time Period, Whichever Comes First.</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigators Will Measure the Required Time for the Successful Venous Cannulation Between Groups.</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Before Attempts of the Cannulation Are Made, Investigators Will Measure the Diameter of the Saphenous Vein With Ultrasound Imaging to Determine if There is Correlation Between Size of the Vein and Success Rate.</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Saphenous Vein Cannulation</condition>
  <arm_group>
    <arm_group_label>Landmark group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An operator is not allowed to use an ultrasound. A 22 or 24 G catheter will be advanced blindly toward the expected location of the saphenous vein at the level of the medial malleolus. Once blood appears in the hub, then the catheter will be advanced into the saphenous vein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An operator will identify the saphenous vein by using ultrasound with a linear transducer (L15-7io) in short axis view. A 22 or 24 G catheter will be advanced until the tip of the needle is seen on the ultrasound image. The needle is then advanced until blood appears in the hub. The catheter is then advanced into the saphenous vein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saphenous vein cannulation</intervention_name>
    <description>Intravenous cannulation to saphenous vein</description>
    <arm_group_label>Landmark group</arm_group_label>
    <arm_group_label>Ultrasound group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ultrasound with a linear transducer (L15-7io)</intervention_name>
    <description>Portable, bed-side ultrasound to detect saphenous vein</description>
    <arm_group_label>Ultrasound group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A 22 or 24 G intravenous catheter</intervention_name>
    <arm_group_label>Landmark group</arm_group_label>
    <arm_group_label>Ultrasound group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pediatric patient undergoing scheduled surgery which requires venous cannulation.

          2. Term neonates and children &lt; 4 years old weighing &gt;/= 3 kg

        Exclusion Criteria:

          1. Patient with visible saphenous vein

          2. Patient with no detectable saphenous vein under ultrasound

          3. Patient with a skin wound or infection around puncture site

          4. Patient with recent venous puncture at the puncture site (less than 1 month)

          5. Patient with thrombus in saphenous vein or hematoma formation around the vein
             detected by ultrasound.

          6. Patient with any emergency surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Satoshi Hanada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa Hospitals &amp; Clinics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Triffterer L, Marhofer P, Willschke H, Machata AM, Reichel G, Benkoe T, Kettner SC. Ultrasound-guided cannulation of the great saphenous vein at the ankle in infants. Br J Anaesth. 2012 Feb;108(2):290-4. doi: 10.1093/bja/aer334. Epub 2011 Oct 27.</citation>
    <PMID>22037223</PMID>
  </reference>
  <reference>
    <citation>Riera A, Langhan M, Northrup V, Santucci K, Chen L. Remember the saphenous: ultrasound evaluation and intravenous site selection of peripheral veins in young children. Pediatr Emerg Care. 2011 Dec;27(12):1121-5. doi: 10.1097/PEC.0b013e31823ab926.</citation>
    <PMID>22134232</PMID>
  </reference>
  <reference>
    <citation>Joshi M, Wilson G, Engelhardt T. Comparison of landmark technique and ultrasound guidance for localisation of long saphenous vein in infants and children. Emerg Med J. 2010 Jun;27(6):443-5. doi: 10.1136/emj.2008.069310.</citation>
    <PMID>20562139</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 31, 2016</lastchanged_date>
  <firstreceived_date>August 14, 2013</firstreceived_date>
  <firstreceived_results_date>March 31, 2016</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Landmark Group</title>
          <description>An operator is not allowed to use an ultrasound. A 22 or 24 G catheter will be advanced blindly toward the expected location of the saphenous vein at the level of the medial malleolus. Once blood appears in the hub, then the catheter will be advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
A 22 or 24 G intravenous catheter</description>
        </group>
        <group group_id="P2">
          <title>Ultrasound Group</title>
          <description>An operator will identify the saphenous vein by using ultrasound with a linear transducer (L15-7io) in short axis view. A 22 or 24 G catheter will be advanced until the tip of the needle is seen on the ultrasound image. The needle is then advanced until blood appears in the hub. The catheter is then advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
ultrasound with a linear transducer (L15-7io): Portable, bed-side ultrasound to detect saphenous vein
A 22 or 24 G intravenous catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Landmark Group</title>
          <description>An operator is not allowed to use an ultrasound. A 22 or 24 G catheter will be advanced blindly toward the expected location of the saphenous vein at the level of the medial malleolus. Once blood appears in the hub, then the catheter will be advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
A 22 or 24 G intravenous catheter</description>
        </group>
        <group group_id="B2">
          <title>Ultrasound Group</title>
          <description>An operator will identify the saphenous vein by using ultrasound with a linear transducer (L15-7io) in short axis view. A 22 or 24 G catheter will be advanced until the tip of the needle is seen on the ultrasound image. The needle is then advanced until blood appears in the hub. The catheter is then advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
ultrasound with a linear transducer (L15-7io): Portable, bed-side ultrasound to detect saphenous vein
A 22 or 24 G intravenous catheter</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12" lower_limit="6" upper_limit="29"/>
                    <measurement group_id="B2" value="8" lower_limit="4" upper_limit="26"/>
                    <measurement group_id="B3" value="11" lower_limit="5" upper_limit="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Primary Object is to Compare the First Attempt Success Rate Between Ultrasound Group and Landmark Group for Saphenous Vein Cannulation.</title>
        <time_frame>10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Landmark Group</title>
            <description>An operator is not allowed to use an ultrasound. A 22 or 24 G catheter will be advanced blindly toward the expected location of the saphenous vein at the level of the medial malleolus. Once blood appears in the hub, then the catheter will be advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
A 22 or 24 G intravenous catheter</description>
          </group>
          <group group_id="O2">
            <title>Ultrasound Group</title>
            <description>An operator will identify the saphenous vein by using ultrasound with a linear transducer (L15-7io) in short axis view. A 22 or 24 G catheter will be advanced until the tip of the needle is seen on the ultrasound image. The needle is then advanced until blood appears in the hub. The catheter is then advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
ultrasound with a linear transducer (L15-7io): Portable, bed-side ultrasound to detect saphenous vein
A 22 or 24 G intravenous catheter</description>
          </group>
        </group_list>
        <measure>
          <title>The Primary Object is to Compare the First Attempt Success Rate Between Ultrasound Group and Landmark Group for Saphenous Vein Cannulation.</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>A Comparison Will be Made Between Groups for Overall Success Rate Within 3 Attempt of Needle Insertions or a 10 Minute Time Period, Whichever Comes First.</title>
        <time_frame>10 minutes</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Investigators Will Measure the Required Time for the Successful Venous Cannulation Between Groups.</title>
        <time_frame>10 minutes</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Before Attempts of the Cannulation Are Made, Investigators Will Measure the Diameter of the Saphenous Vein With Ultrasound Imaging to Determine if There is Correlation Between Size of the Vein and Success Rate.</title>
        <time_frame>10 minutes</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Landmark Group</title>
          <description>An operator is not allowed to use an ultrasound. A 22 or 24 G catheter will be advanced blindly toward the expected location of the saphenous vein at the level of the medial malleolus. Once blood appears in the hub, then the catheter will be advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
A 22 or 24 G intravenous catheter</description>
        </group>
        <group group_id="E2">
          <title>Ultrasound Group</title>
          <description>An operator will identify the saphenous vein by using ultrasound with a linear transducer (L15-7io) in short axis view. A 22 or 24 G catheter will be advanced until the tip of the needle is seen on the ultrasound image. The needle is then advanced until blood appears in the hub. The catheter is then advanced into the saphenous vein.
Saphenous vein cannulation: Intravenous cannulation to saphenous vein
ultrasound with a linear transducer (L15-7io): Portable, bed-side ultrasound to detect saphenous vein
A 22 or 24 G intravenous catheter</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Satoshi Hanada/Clinical Assistant Professor</name_or_title>
      <organization>University of Iowa Hopspital &amp; Clinics</organization>
      <phone>3193561219</phone>
      <email>satoshi-hanada@uiowa.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
